We hear that a UK NHS Trust, one of several to have set up healthcare facilities in the GCC in the past decade, is close to offloading its Abu Dhabi clinic to a local private operator. We discuss the success of NHS Trusts in the GCC generally.
Pan-Nordic care provider Ambea has released Q2 2019 results showing its Norwegian business requires "a lot more work" before achieving a successful turnaround and margin improvement. Group-wide sales nearly doubled thanks to its recent large acquisition although grow only 1% organically. The results were well-received by the market. Its share price rose 8% to a high of SEK 74 (€6.80) over the morning of the results day, Tuesday August 20th.
Belfast-based domiciliary care provider Connected Health has expanded into the Republic and claims to be growing its workforce exponentially. We speak to a director at the company and take a look at the Irish market.
Uniquely, we think in Europe, Tiohundra, an organisation serving a municipality of 62,000, has fully merged social care and health care delivery. Social care (elderly care, disabled care, homecare, psychiatry) and health care (hospitals and primary care) – have been melded in to a single organisation. So what are the learnings? And are we going […]
Does Europe's imaging equipment supply oligopoly - Siemens Healthineers, Philips and GE Healthcare - face a threat from cheaper Chinese alternatives? Two service operators give HBI different viewpoints.
The Evercare Health Fund, formerly Abraaj's Growth Markets Health Fund (AGHF) before the PE firm's fall from grace and now managed by TPG, is finally starting to deliver on its big greenfield projects in the most difficult emerging markets, with the Pakistan hospital recently opened and the Lagos, Nigeria, facility expected in Q2 2020. We talk to a source close to Evercare about the Lahore hospital, the whole platform today and the strategy going forward.
German mid-market domiciliary care provider SunaCare claims it will double in size by next year. Is this viable in the midst of a staffing crisis? HBI talks to the company's senior strategist to find out more.
We talk to consultancy Alvarez & Marsal's (A&M) recently-appointed head of European Healthcare & Life Sciences industry practice, medtech specialist Ray Berglund, about the sector's move into healthcare services.
HBI talks to Tim Clover, CEO of ophthalmology medtech supplier Rayner and former CEO of ophthalmology operator Optegra about his take on the market, challenges and opportunities in the future, and plans for the company going forward, including coming to market in the next two years - or sooner.
We talk to the CFO of Turkey's largest private hospital group by beds, MLP Care, 18 months on from its Istanbul listing. Burcu Ozturk discusses the Turkish economy, MLP's postponed M&A plans and growing its private and international revenues amidst a stagnant statutory insurance segment.
Fresenius Helios has formed a new telemedicine joint-venture that will create an occupational healthcare tool to increase patient flow in Germany. The company exclusively tells HBI it wants to roll out to Spain.
Brazil's biggest lab company Dasa has said it expects its genetic testing subsidiary to be worth more than its core routine testing business within ten years as it opens LATAM's "largest" sequencing facility.
Advent International, the big-spending PE firm which has just bought franchise-focussed Spanish dental chain Vitaldent, is planning to put millions into the business with a view to floating, according to local reports. We speak to a well-placed operator source who is surprised by the speed with which Advent seems willing to splash the cash for its latest acquisition.
After overseeing a four-fold rise in revenue, a change in culture and a move to digitalisation, Yrjö Närhinen, 49, the CEO of Terveystalo, the listed Finnish outpatient group, has decided to step down after an 8-year stint at the helm. We talk to him about the future. It is a little known fact that compared to the size of the country, Terveystalo is the largest healthcare group in Europe, employing one in 400 of the working population.
Will international dialysis group Diaverum IPO or sell? We catch up with its new CEO, the former boss of international imaging group Affidea. Rarely have we met such an enthusiastic leader. That may be just as well. Many wonder whether Diaverum, which has been owned by private equity house Bridgepoint since 2007, can ever be sexed up enough to attract a top price. If anyone can achieve this, it is Moulavasilis.
The price of pharmacies in Italy is soaring, HBI hears – and one new group looks to be setting the early pace in the race to create a network after legislation was passed allowing corporate ownership. Previously, pharmacy businesses could only be owned by licenced pharmacists but, on the recommendation of the Italian Competition Authority, […]